Jugular Interventions for Multiple Sclerosis and Chronic Cerebrospinal Venous Insufficiency

  • Jason P. Vachon
  • Gary P. Siskin


Multiple sclerosis (MS) is a chronic inflammatory disease resulting in demyelination of the central nervous system. First described pathologically by Robert Carswell in 1838, this disorder typically arises in young adults with approximately 12,000 new diagnoses each year in the United States alone. While the precise cause of this disease has yet to be elucidated, a combination of genetic and environmental factors is felt to be responsible for the autoimmune-mediated nature of this condition.


  1. 1.
    Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372:1502–17.PubMedCrossRefGoogle Scholar
  2. 2.
    Alonso A, Hernán M. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology. 2008;72:129–35.CrossRefGoogle Scholar
  3. 3.
    Ramagopalan S, Dobson R, Meier UC, Giovannoni G. Multiple sclerosis: risk factors, prodromes and potential causal pathways. Lancet Neurol. 2010;9:727–39.PubMedCrossRefGoogle Scholar
  4. 4.
    Zamboni P. The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med. 2006;99:589–93.PubMedCrossRefGoogle Scholar
  5. 5.
    Zamboni P et al. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2009;80:392–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Zamboni P, Menegatti E, Galeotti R, et al. The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis. J Neurol Sci. 2009;282:21–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Simka M et al. Extracranial Doppler sonographic criteria of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. Int Angiol. 2010;29:109–14.PubMedGoogle Scholar
  8. 8.
    Zivadinov R et al. Prevalence, sensitivity and specificity of chronic cerebrospinal venous insufficiency in MS. Neurology. 2011;77:138–44.PubMedCrossRefGoogle Scholar
  9. 9.
    Al-Omari M et al. Internal jugular vein morphology and hemodynamics with multiple sclerosis. Int Angiol. 2010;29:115–20.PubMedGoogle Scholar
  10. 10.
    Haacke EM, Feng W, Utriainen D, et al. Patients with multiple sclerosis with structural venous abnormalities on MR imaging exhibit an abnormal flow distribution of the internal jugular veins. J Vasc Interv Radiol. 2012;23:60–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Doepp F et al. No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol. 2010;68:173–83.PubMedGoogle Scholar
  12. 12.
    Tsivgoulis G, Manatzis M, Bogiatzi C, et al. Extracranial venous hemodynamics in multiple sclerosis: a case–control study. Neurology. 2011;77:1241–5.PubMedCrossRefGoogle Scholar
  13. 13.
    Centonze D, Floris R, Stafanini M, et al. Proposed chronic cerebrospinal venous insufficiency criteria do not predict multiple sclerosis risk or severity. Ann Neurol. 2011;70:51–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Mayer C. The perfect crime? CCSVI not leaving a trace in MS. J Neurol Neurosurg Psychiatry. 2011;82:436–40.PubMedCrossRefGoogle Scholar
  15. 15.
    Baracchini C, Perini P, Causin F, et al. Progressive multiple sclerosis is not associated with chronic cerebrospinal venous insufficiency. Neurology. 2011;77:844–50.PubMedCrossRefGoogle Scholar
  16. 16.
    Marder E, Gupta P, Greenberg BM, et al. No cerebral or cervical venous insufficiency in US veterans with multiple sclerosis. Arch Neurol. 2011;68:1521–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Hojnacki D, Zamboni P, Lopez-Soriano A, et al. Use of neck magnetic resonance venography, Doppler sonography and selective venography for diagnosis of chronic cerebrospinal venous insufficiency: a pilot study in multiple sclerosis patients and healthy controls. Int Angiol. 2010;29:127–39.PubMedGoogle Scholar
  18. 18.
    Zamboni P et al. A prospective open label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg. 2009;50:1348–58.PubMedCrossRefGoogle Scholar
  19. 19.
    Malagoni AM, Galeotti R, Menegatti E, et al. Is chronic fatigue the symptom of venous insufficiency associated with multiple sclerosis? A longitudinal pilot study. Int Angiol. 2010;29:176–82.PubMedGoogle Scholar
  20. 20.
    Dake MD, Dantzker N, Bennett WL, Cooke JP. Endovascular correction of cerebrovenous anomalies in multiple sclerosis: a retrospective review of an uncontrolled case series. Vasc Med. 2012; 17:131–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Aboulker J, Aubin ML, Leriche H, et al. Intraspinal venous hypertension due to multiple anomalies in the caval system. A major cause of myelopathies. Acta Radiol Suppl. 1976;347:395–401.PubMedGoogle Scholar
  22. 22.
    Morimoto A et al. Assessment of cervical venous blood flow and the craniocervical venous valve using ultrasound. Leg Med. 2009;11:10–7.CrossRefGoogle Scholar
  23. 23.
    Werner J, Siskin GP, Mandato K, Englander M, Herr A. Review of venous anatomy for venographic interpretation in chronic cerebrospinal venous insufficiency. J Vasc Interv Radiol. 2011;22:1681–90.PubMedCrossRefGoogle Scholar
  24. 24.
    Patra P et al. Physiologic variations of the internal jugular vein surface, role of the omohyoid muscle, a preliminary echographic study. Surg Radiol Anat. 1988;10:107–12.PubMedCrossRefGoogle Scholar
  25. 25.
    Escott EJ, Branstetter BF. It’s not a cervical lymph node, it’s a vein: CT and MR imaging findings in the veins of the head and neck. Radiographics. 2006;26:1501–15.PubMedCrossRefGoogle Scholar
  26. 26.
    Lim CL, Keshava SN, Lea M. Anatomical variations of the internal jugular veins and their relationship to the carotid arties: a CT evaluation. Australas Radiol. 2006;50:314–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Diaconu C, Staugaitis S, McBride J, et al. Anatomical and histological analysis of venous structures associated with chronic cerebrospinal venous insufficiency [abstract 134]. In: 5’th joint triennial congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis, Amsterdam, October 2011.Google Scholar
  28. 28.
    Petrov I, Grozdinski L, Kaninski G, et al. Safety profile of endovascular treatment for chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Endovasc Ther. 2011;18:314–23.PubMedCrossRefGoogle Scholar
  29. 29.
    Ludyga T, Kazibudzki M, Simka M, et al. Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe? Phlebology. 2010;25:286–95.PubMedCrossRefGoogle Scholar
  30. 30.
    Mandato KD, Hegener PF, Siskin GP, et al. Safety of endovascular treatment of chronic cerebrospinal venous insufficiency: a report of 240 patients with multiple sclerosis. J Vasc Interv Radiol. 2012;23:55–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Qiu J. Venous abnormalities and multiple sclerosis: another breakthrough claim? Lancet Neurol. 2010;9:464–5.PubMedCrossRefGoogle Scholar
  32. 32.
    Burton JM, Alikhani K, Goyal M. Complications in MS patients after CCSVI procedures abroad (Calgary, AB). Can J Neurol Sci. 2011;38:741–6.PubMedGoogle Scholar
  33. 33.
    Aksungar FB, Topkaya AE, Yildiz Z, et al. Coagulation status and biochemical and inflammatory markers in multiple sclerosis. J Clin Neurosci. 2008;15:393–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Nappo F, De Rosa N, Marfella R, et al. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA. 1999;281:2113–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Kuch B, Bobak M, Fobker M, et al. Associations between homocysteine and coagulation factors – a cross sectional study in two populations of central Europe. Thromb Res. 2001;103:265–73.PubMedCrossRefGoogle Scholar
  36. 36.
    Nathanson M, Savitsky JP. Platelet adhesiveness index studies in multiple sclerosis and other neurologic disorders. Bull N Y Acad Med. 1952;28:462–8.PubMedGoogle Scholar
  37. 37.
    Wright HP, Thompson RHS, Zikha KJ. Platelet adhesiveness in multiple sclerosis. Lancet. 1965;2:1109–10.PubMedCrossRefGoogle Scholar
  38. 38.
    Sheremata WA, Jy W, Horstman LL, et al. Evidence of platelet activation in multiple sclerosis. J Neuroinflammation. 2008;5:27.PubMedCrossRefGoogle Scholar
  39. 39.
    Bidot CJ, Horstman LL, Jy W, et al. Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study. BMC Neurol. 2007;7:36.PubMedCrossRefGoogle Scholar
  40. 40.
    Donnet A, Metellus P, Levrier O, et al. Endovascular treatment of idiopathic intracranial hypertension: clinical and radiologic outcome of 10 consecutive patients. Neurology. 2008;70:641–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Bussiere M, Falero R, Nicolle D, et al. Unilateral transverse sinus stenting of patients with idiopathic intracranial hypertension. AJNR Am J Neuroradiol. 2010;31:645–50.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Jason P. Vachon
    • 1
  • Gary P. Siskin
    • 1
  1. 1.Department of RadiologyAlbany Medical Center HospitalAlbanyUSA

Personalised recommendations